Urine metabolomics analysis of patients recovered of the Omicron variant of COVID-19 using ultrahigh-performance liquid chromatography with high-resolution mass spectrometry

TANG, Zhizhong; BAI, Yunpeng; XU, Wang; LAI, Changchun; WANG, Yirong; LI, Yaocai; HUANG, Cuizhu; LI, Ying; JIANG, Xinyi; LI, Yingbang; CHEN, Xiyan; HU, Linhui; CHEN, Chunbo

doi:10.1016/j.cjac.2023.100314

Chinese Journal of Analytical Chemistry

2023

DOI: 10.1016/j.cjac.2023.100314

|View full text |Cite

Urine metabolomics analysis of patients recovered of the Omicron variant of COVID-19 using ultrahigh-performance liquid chromatography with high-resolution mass spectrometry

Zhizhong TANG,

Yunpeng BAI,

Wang XU

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Diagnosis, Severity, and Prognosis from Potential Biomarkers of COVID-19 in Urine: A Review of Clinical and Omics Results

Narro-Serrano,

Marhuenda-Egea

2024

Metabolites

View full text Add to dashboard Cite

The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has spurred an extraordinary scientific effort to better understand the disease’s pathophysiology and develop diagnostic and prognostic tools to guide more precise and effective clinical management. Among the biological samples analyzed for biomarker identification, urine stands out due to its low risk of infection, non-invasive collection, and suitability for frequent, large-volume sampling. Integrating data from omics studies with standard biochemical analyses offers a deeper and more comprehensive understanding of COVID-19. This review aims to provide a detailed summary of studies published to date that have applied omics and clinical analyses on urine samples to identify potential biomarkers for COVID-19. In July 2024, an advanced search was conducted in Web of Science using the query: “covid* (Topic) AND urine (Topic) AND metabol* (Topic)”. The search included results published up to 14 October 2024. The studies retrieved from this digital search were evaluated through a two-step screening process: first by reviewing titles and abstracts for eligibility, and then by retrieving and assessing the full texts of articles that met the specific criteria. The initial search retrieved 913 studies, of which 45 articles were ultimately included in this review. The most robust biomarkers identified include kynurenine, neopterin, total proteins, red blood cells, ACE2, citric acid, ketone bodies, hypoxanthine, amino acids, and glucose. The biological causes underlying these alterations reflect the multisystemic impact of COVID-19, highlighting key processes such as systemic inflammation, renal dysfunction, critical hypoxia, and metabolic stress.

show abstract

Diagnosis, Severity, and Prognosis from Potential Biomarkers of COVID-19 in Urine: A Review of Clinical and Omics Results

Narro-Serrano,

Marhuenda-Egea

2024

Metabolites

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Urine metabolomics analysis of patients recovered of the Omicron variant of COVID-19 using ultrahigh-performance liquid chromatography with high-resolution mass spectrometry

Cited by 1 publication

References 39 publications

Diagnosis, Severity, and Prognosis from Potential Biomarkers of COVID-19 in Urine: A Review of Clinical and Omics Results

Diagnosis, Severity, and Prognosis from Potential Biomarkers of COVID-19 in Urine: A Review of Clinical and Omics Results

Contact Info

Product

Resources

About